Novartis Prevails In Patent Suit Vs. Dr. Reddy's Over Lamisil

Law360, New York (September 3, 2004, 12:00 AM EDT) -- Swiss drug giant Novartis has fended off a patent challenge from Indian generic maker Dr. Reddy’s against its widely prescribed oral antifungant Lamisil.

Dr. Reddy's Laboratories withdrew its challenge to the Lamisil patent and conceded that it is valid, enforceable and had been infringed by the Indian generic maker, Novartis said Friday.

Dr. Reddy's said it pulled its legal challenge “because the time needed to obtain a favorable Federal Circuit decision prior to patent expiration would not be met.”

Novartis filed the lawsuit the U.S. District...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.